Clinicians and health-industry leaders will find an analysis of shifting treatment demand and strategic responses across care, coverage, and operations.
Key Takeaways
- GLP-1 medications are increasingly prescribed to older adults for weight and metabolic management
- Payers are reshaping coverage policies and cost-management approaches for aging patient populations
- Care teams must adjust monitoring, comorbidity management, and dosing strategies for senior patients